Astrana Health Inc. Common Stock (ASTH) is a publicly traded Healthcare sector company. As of May 21, 2026, ASTH trades at $38.63 with a market cap of $1.93B and a P/E ratio of 82.85. ASTH moved -1.22% today. Year to date, ASTH is +41.46%; over the trailing twelve months it is +43.13%. Its 52-week range spans $18.08 to $63.20. Analyst consensus is strong buy with an average price target of $41.57. Rallies surfaces ASTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ASTH combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $38.63 |
| Market Cap | $1.93B |
| P/E Ratio | 82.85 |
| EPS | $0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $63.20 |
| 52-Week Low | $18.08 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.18B |
| Net Income | $24.08M |
| Gross Margin | 0.00% |
9 analysts cover ASTH: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.57.